Respiratory

Relieving symptoms and optimizing therapies for allergic rhinitis

Nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals) has been approved for the treatment of chronic fibrosing interstitial lung disease with a progressive phenotype.

Solid recommendations can require detective work. 

The FDA is requesting that manufacturers of bacitracin for injection voluntarily withdraw their product. 

Data tracked by wearable fitness sensors may help with real-time surveillance of seasonal respiratory infections, such as influenza.

The 2019 Novel Coronavirus outbreak in Wuhan City, China has caused concern as 2 cases have been recently reported in the United States.

Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.

A new study of a vaccine used against a pneumonia-causing bacteria found that cases of severe pneumonia decreased by 35% among those children who had received the vaccine.

Pharmacists can play an integral role in transitions-of-care for patients with chronic obstructive pulmonary disease (COPD) to prevent hospital readmissions.

Tips to help COPD patients decrease their flare-up risks.

The range of inhaled therapies has expanded dramatically in recent years.

Direct and concise information will dissuade dangerous use.

Fewer tracheobronchial branches may be a genetically-related risk factor.

Regular exercise can be an effective way to delay the onset and acceleration of COPD.

"I’ve yet to meet a pharmacist who ever had this covered in pharmacy school," writes Kreckel. 

Commercial launch suspended due to manufacturer liquidity.

The drug comes at a time when antibiotic resistance worries are high. Here’s why it matters.

Whether marijuana use increases COPD susceptibility remains uncertain.

Only 50% of COPD patients are estimated to be vaccinated.

New medications and treatment guidelines

Oral kinase inhibitor for SSc-ILD.

Imaging techniques, stem cell therapy, and more!

Prescriptions for COPD contribute to antimicrobial resistance.

New pleuromutilin antibiotic IV and oral tablets.